Measles Outbreak Response Immunization Is Context-Specific: Insight from the Recent Experience of Médecins Sans Frontières
article has not abstract
Vyšlo v časopise:
Measles Outbreak Response Immunization Is Context-Specific: Insight from the Recent Experience of Médecins Sans Frontières. PLoS Med 10(11): e32767. doi:10.1371/journal.pmed.1001544
Kategorie:
Policy Forum
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001544
Souhrn
article has not abstract
Zdroje
1. World Health Organization (2003) World Health Assembly resolution WHA 52.20. Reducing global measles mortality. Geneva: World Health Organization.
2. Centers for Disease Control and Prevention (2007) Progress in global measles control and mortality reduction, 2000–2006. MMWR Morb Mortal Wkly Rep 56: 1237–1241.
3. WolfsonLJ, StrebelPM, Gacic-DoboM, HoekstraEJ, McFarlandJW, et al. (2007) Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study. Lancet 369: 191–200.
4. Centers for Disease Control and Prevention (2009) Progress toward measles control—African region, 2001–2008. (2009). MMWR Morb Mortal Wkly Rep 58: 1036–1041.
5. World Health Organization, United Nations Children's Fund (2005) Global immunization vision and strategy 2006–2015. Report WHO/IVB/05.05. Available: http://whqlibdoc.who.int/hq/2005/WHO_IVB_05.05.pdf. Accessed 2 October 2013.
6. SimonsE, FerrariM, FricksJ, WannemuehlerK, AnandA, et al. (2012) Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data. Lancet 379: 2173–2178.
7. World Health Organization Regional Office for Africa (2009) Towards the elimination of measles in the African Region by 2020. Report AFR/RC59/14. Kigali: World Health Organization Regional Office for Africa.
8. BiellikR, MademaS, TaoleA, KutsulukutaA, AlliesE, et al. (2002) First 5 years of measles elimination in southern Africa: 1996–2000. Lancet 359: 1564–1568.
9. Measles outbreaks and progress towards meeting measles pre-elimination goals: WHO African Region,2009–2010. Wkly Epidemiol Rec 86: 129–136.
10. MinettiA, KagoliM, KatsulukutaA, HuergaH, FeatherstoneA, et al. (2013) Lessons and challenges for measles control from unexpected large outbreak, Malawi. Emerg Infect Dis 19: 202–209.
11. World Health Organization (2011) Measles reported cases. Available: http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tsincidencemeasles.html. Accessed 2 October 2013.
12. MossWJ, GriffinDE (2012) Measles. Lancet 379: 153–164.
13. World Health Organization (2009) Response to measles outbreaks in measles mortality reduction settings. Report WHO/IVB/09.03. Available: http://whqlibdoc.who.int/hq/2009/WHO_IVB_09.03_eng.pdf. Accessed 2 October 2013.
14. The Sphere Project (2004) The sphere handbook: humanitarian charter and minimum standards in disaster response. Geneva: The Sphere Project.
15. GraisRF, StrebelP, MalaP, WatsonJ, NandyR, et al. (2011) Measles vaccination in humanitarian emergencies: a review of recent practice. Confl Health 5: 21.
16. GoodsonJL, MasreshaBG, WannemuehlerK, UzicaninA, CochiS (2011) Changing epidemiology of measles in Africa. J Infect Dis 204: S205–S214.
17. WolfsonLJ, GraisRF, LuqueroFJ, BirminghamME, StrebelPM (2009) Estimates of measles case fatality ratios: a comprehensive review of community-based studies. Int J Epidemiol 38: 192–205.
18. GraisRF, DubrayC, GerstlS, GuthmannJP, Djiboa, et al. (2007) Unacceptably high mortality related to measles epidemics in Niger, Nigeria, and Chad. PLoS Med 4: e16 doi:10.1371/journal.pmed.0040016
19. GroutL, MinettiA, HurtadoN, FrançoisG, FermonF, et al. (2013) Measles in Democratic Republic of Congo: an outbreak description from Katanga, 2010–2011. BMC Infect Dis 13: 232.
20. MetcalfCJE, KlepacP, FerrariM, GraisRF, DjiboA, et al. (2011) Modelling the first dose of measles vaccination: the role of maternal immunity, demographic factors, and delivery systems. Epidemiol Infect 139: 265–274.
21. LeuridanE, HensN, HutseV, IevenM, AertsM, et al. (2010) Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. BMJ 340: c1626.
22. MartinsCL, GarlyM-L, BaléC, RodriguesA, RavnH, et al. (2008) Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial. BMJ 337: a661.
23. AabyP, BennCS (2011) Non-specific and sex-differential effects of routine vaccines: what evidence is needed to take these effects into consideration in low-income countries? Hum Vaccin 7: 120–124.
24. National Statistical Office of Malawi (2012) 2008 population and housing census. Available: http://www.nsomalawi.mw/index.php/2008-population-and-housing-census.html. Accessed 7 October 2013.
25. Democratic Republic of the Congo Ministry of Planning (2008) Democratic Republic of the Congo Demographic and Health Survey 2007: key findings. Available: http://www.measuredhs.com/pubs/pdf/SR141/SR141.pdf. Accessed 7 October 2013.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2013 Číslo 11
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Nech brouka žít… Ať žije astma!
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
Najčítanejšie v tomto čísle
- A Brief Patient-Reported Outcomes Quality of Life (PROQOL) Instrument to Improve Patient Care
- Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010
- From Ideals to Tools: Applying Human Rights to Maternal Health
- Role of DNA Methylation and Epigenetic Silencing of in Endometrial Cancer Development